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Hislone HI acts as a general repressor of transcription i eukaryotcs by organizing nueleosomcs into inaccessible condensed forms of chromatin, 
The capability of HI to bind to DNA with some sequence specificity is Likely to be critical in the control of tl~cse processes. We show I,¢re thai 
ATP and several other nu¢leotides, including non-hydrolyzable d rivatives, can inhibit DNA binding of HI. The results also show thal ATP 
differentially affects binding of HI to DNA in a fashion enhancing nu¢leotide sequen¢~ specificity of the binding. The study suggests a novel 
mechanism of modulation of H1 activity that has important implications for lhe role of HI as a traa~:riptional regulator. 
Chromatin; Nucl,otide; Histone HI" DNA bindin/~ 
1. INTRODUCTION 
Histone HI plays a central role as general repressor 
of transcription in eukaryotes by organizing nucleo- 
somes into condensed forms of chromatin, thereby ren- 
dering the DNA inaccessible [1-4]. Antirepression of 
HI-mediated inhibition of transcription is a distinct ac- 
tivity of transcription factors [5]. 
HI displays nucleotide sequence specificity in its 
DNA binding [6-11]. The sequence recognized by H! 
is closely related to that of other proteins that bind to 
NFI sites [10,11]. The fold of the central globular do- 
iiiair, of" histone H5, an H 1 variant, is very similar to the 
DNA binding domain of the cAMP receptor protein of 
Escherichkt coli [12]. Both basic ends of HI contain 
repeats of a motif° Ser.Pro-Lys/Arg-Lys/Arg, with 
DNA-binding capacity [13,14]. HI also contains a con- 
served segment with homology to nucleotide binding 
domains in diverse nucleotide-binding proteins [i 5-17], 
and nucleotides can bind to HI [16,18,19]. in this report 
we analyze the importance of the nucleotide interaction 
and show that nucleotides differentially affect he DNA 
binding of HI. 
2. MATERIALS AND METHODS 
H I was purified Fronl rat liver a,~ previously described [I l,l 6]. Eiec- 
trophoretic mobility shift assays (EM SA) were as described [20] ex¢~pt 
that reaction~ contained 25 n~ each of poly (dl-dC) and polyfdA-dT). 
13 ng o1"!41 per reaction was used, and where indicated, nucleotide~ 
(Sigma) were included in preineubation of HI for 10 rain at room 
temperature prior to addition of" DNA, 
(~Ol'F¢.~'p~lllfletlCt" glf~£tre&~'." P  l " l l l~b 'O l ' l  4 Departmant " ^- - ' : -  
Molecutar Biology, University of Ume',L S.901 87 Ume~l, Sweden, 
Fax: (46) (90) i I l 420. 
Double-stranded DNA se~,ments tnumbers 2, 34. 36, 42 and 43 of 
[I 0], and the x3 motif of the x chain enhancer [211) were prepared from 
oligonu¢leotides (Symbicom) as described [20 l, 
3. RESULTS AND DISCUSSION 
Increasing concentrations of ATP were added to H 1 
in an EMSA, using a double-stranded oligomlcleotide 
with the Hi binding site of the SL3-3 virus enhancer 
[lO]. To minimize non-specific H I.DNA interaction, 
each reactio:~ contained a 2,000-fold excess of double- 
stranded poly(dl-dC) and poly(dA-dT) and 0.1 pmol of 
single-stranded DNA. The data show a clear hahibition 
of H1-DNA bindingby ATP (Figs. I and 2). 50% inhi- 
bition was obtained at 2.3 mM ATP and 80% inhibition 
at 8 mM ATP (Fig. I). These concentrations are in the 
range of tile physiological ATP concentration of 3-5 
mM [22,23], 
The less abundant nucleotides, GTP, UTP, CTP, 
dATP and dGTP, nit inhibited H I-DNA binding to 
about he same xtent, and at about he same concentra- 
tion, as did ATP (Fig. 2). Thus, inhibition of H I-DNA 
binding is not specific for the type of base or for the 
presence of ribose or deoxyribose. Non-hydrolyzable 
nucleotide analogues, 5'-adenylylimidodiphosphate 
(AMP-PNP) and 5'-guanylylimidodiphosphatc (GMP- 
PN P) also inhibited H I-DNA binding. ADP gave vari- 
able results, but in all e~.periments ADP was less inhib- 
itory than the nucleoside triphosphates. Neither of the 
nueleo~ide monophosphates, AMP or cAMP, resulted 
in any inhibition (Fig. 2). Thus, the observed inhibition 
depended on the presence of more than one phosphate 
in the compound. Finally, pyroplaosphate or fl-giycero- 
phosphate had no efl~ect on the binding of H 1 (data not 
P.bliahed by ELl'crier Sct ettce Publfshers B, IL 67 
Volume 313, number 1 FEBS LETTERS November 1992 
._= t-,, 
t~  
n'- 
1~0f o 
100 ° 
80- 
60- 
40- 
20- 
o I 
o 
o 0 
0 
O 
O 
3 4 
o o 
oo 
Oc 
i ! i i 
5 8 7 8 
ATP (raM) 
Fig. I. Inhibition by ATP of complex formation between hi,tone HI 
and the HI binding ~ite of the SL3-3 virus ~nhan¢¢r in EMSA, 
shown). Thus, there are clear structural requirements on
the compounds capable of inhibition. 
It was of interest to compare the effect of ATP on HI 
binding to the SL3-3 site and to other DNA sequences. 
The sequences were as follows; the H1 site Ln the SL3-3 
enhancer, two others of rottghly the same intermediate 
binding strength [10]; and two much stronger H1 bind- 
ing sites, the site of adenovirus 2/5 (Ad2/5) and our 
proposed optimized HI binding sequence [10]. Non- 
specific control DNA did not compete with H1 binding 
to the SL3-3 site (Fig. 3). The site of SL3-30 the half-site 
of the albumin gene and the optimized half-site could 
all compete without any differential effect of 3 mM ATP 
(Fig. 3). Thus° half-sites are not more sensitive to inhibi- 
tion with nucleotides than palindromic binding sites of 
similar strength. In contrast, he strong H 1 binding site 
of Ad2/5 and our proposed optimized binding ~ite were 
both clearly better competitors in the presence of 3 mM 
ATP (Fig. 3). Thus, ATP increases the stringency of 
sequence-specific H I-DNA binding. This interpreta- 
tion is supported by analyses of the amounts of com- 
plexes with the DNA segments, both in the presence and 
absence of poly(dI-dC) and poly(dA-dT) competitors 
(data not shown). 
Our data argue against he possibility that nucleo- 
tides inhibit H1-DNA binding by functioning as a 
DNA analogue, or that hydrolysis of the nucleotid¢ 
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Fig. 2. l~fl'ects of different nucleotides and rela,'ed analogues ell histoae HI--D,NA. binding. The fixml concentrations of reagents (mM) are indicated 
above each lane. 
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Fig. 3. Eff~t of ATP on competition of histone H 1 binding to the SL3-3 site by variou~ histon¢ H l bmt~mg s~tes. "i'l~e molar excess of the competitor 
i~ indicated above each lane. 
could lead to interference with tne ability of H 1 to inter- 
act with DNA. The data rather favour the possibility 
that the inhibiti.on is an effect of binding of nacleotidc 
to H1, either due to a physical overlap between the 
nttcleotide and DNA binding sites, or to an allosteric 
effect on the DNA binding. The preferential inhibition 
of moder~,,te s~.rength H 1 binding sites over strong sites 
could indicate competition between ucleotide and spe- 
cific DNA for binding of HI. On the other hand, the 
slope of the inhibition curve could indicate transition 
between two co,aformations. 
The finding that physiological levels of ATP affect 
H I -DNA binding in vitro indicates a direct connection 
between the availability of energy as ATP in the cell 
nucleus and the ability of HI to bind to DNA in vivo. 
Since HI acts as a general repressor, our results favour 
a direct coupling between the availability of energy as 
ATP and the accessibility of various genes to tran-~crip- 
tional activators. 
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